1 domain, and a tetra alanine substitution at amino acids 296 299 in the protease domain. Tenecteplase ... matrix of the thrombus. Tenecteplase has a higher fibrin specificity and greater resistance to inactivation by its endogenous inhibitor PAI 1 compared to native t PA. Tenecteplase is indicated in thrombolytic ..., Yoho J, Tantry U title The platelet related effects of tenecteplase versus alteplase versus reteplase ... G, Laule M title Tenecteplase for the treatment of massive and submassive pulmonary embolism ..., Oliverio R, Harrelson L, McCabe C, DiBattiste P, Braunwald E title Tenecteplase and tirofiban in ST ... De Luca G, Suryapranata H, Chiariello M title Tenecteplase followed by immediate angioplasty is more effective than tenecteplase alone for people with STEMI. Commentary. journal Evid Based Cardiovasc ... author title Primary versus tenecteplase facilitated percutaneous coronary intervention in patients ... tenecteplase is associated with increased return of spontaneous circulation and short term survival ... author Hull J, Hull M, Urso J, Park H title Tenecteplase in Acute Lower leg Ischemia Efficacy, Dose ... stub it Tenecteplase pt Tenecteplase ... more details
TNK is a three letter acronym that may refer to Hebrew Bible The Hebrew Bible. See also Tanakh . Tenecteplase TNK an enzyme used as a thrombolysis thrombolytic drug. TNK BP TNK BP Ltd. a Russian oil company. The Japanese animation studio TNK company TNK . The Beatles song Tomorrow Never Knows , the final track of The Beatles 1966 studio album Revolver . disambig de TNK fr TNK homonymie it TNK ja TNK ... more details
Mergeto Thrombolysis discuss Talk Thrombolysis Merger proposal date April 2009 Thrombolytic drugs are used in medicine to dissolve thrombus blood clots in a procedure termed thrombolysis . They limit the damage caused by the blockage of the blood vessel . Uses Thrombolysis is used in myocardial infarction heart attack , Stroke Ischemic thromboembolic strokes , deep vein thrombosis and pulmonary embolism to clear a blocked artery and avoid permanent damage to the perfused tissue e.g. myocardium , brain , leg and death . A less frequent use is to clear blocked catheter s that are used in long term medical therapy. Thrombolytic therapy in Stroke Hemorrhagic hemorrhagic stroke s is contraindicated , as its use in that situation would prolong bleeding into the intracranial space and cause further damage. Bleeding worksheet Members The thrombolytic drugs include tissue plasminogen activator t PA alteplase Activase reteplase Retavase tenecteplase TNKase anistreplase Eminase streptokinase Kabikinase , Streptase urokinase Abbokinase These drugs are most effective if administered immediately after it has been determined they are clinically appropriate. The advantage of administration is highest within the first sixty minutes, but may extend up to six hours after the start of symptoms. The drugs are often given in combination with intravenous heparin , or low molecular weight heparin , which are anticoagulant drug s. Side effects Hemorrhagic stroke is a rare but serious complication of thrombolytic therapy. If a patient has had thrombolysis before, an allergy against the thrombolytic drug may have developed especially after streptokinase . If the symptoms are mild, the infusion is stopped and the patient is commenced on an antihistamine before infusion is recommenced. Anaphylaxis generally requires immediate cessation of thrombolysis. See also thrombolysis anticoagulant drug s antiplatelet drug s antiaggregants References Reflist Antithrombotics Major Drug Groups DEFAULTSORT T ... more details
Merge from Thrombolytic drug discuss Talk Thrombolysis Merger proposal date April 2009 Refimprove date January 2009 Thrombolysis is the breakdown lysis of thrombosis blood clots ref DorlandsDict eight 000108543 thrombolysis ref by pharmacology pharmacological means. It is colloquially referred to as clot busting for this reason. It works by stimulating fibrinolysis by plasmin through infusion of analogs of tissue plasminogen activator tPA , the protein that normally activates plasmin. Agents Thrombolysis suggests the use of thrombolytic drug s, which are either derived from Streptomyces species, or, more recently, using Recombinant DNA recombinant Biotechnology Pharmaceutical products biotechnology whereby tPA is manufactured by bacteria , resulting in a recombinant tissue plasminogen activator or rtPA. Some commonly used thrombolytics are streptokinase urokinase Recombinant tissue plasminogen activator s alteplase rtPA reteplase tenecteplase Principles Formation of blood clots lies at the basis of a number of serious diseases see below . By breaking down the clot, the disease process can be arrested, or the complications reduced. While other anticoagulant s such as heparin decrease the growth of a clot, thrombolytic agents actively reduce the size of the clot. Most thrombolytic agents work by activating the enzyme plasminogen , which clears the cross linked fibrin mesh the backbone of a clot . This makes the clot soluble and subject to further proteolysis by other enzymes, and restores blood flow over occluded blood vessel s. Uses Diseases where thrombolysis is used Myocardial infarction Stroke ischemic stroke ref name pmid12917889 cite journal author Wardlaw JM, Zoppo G, Yamaguchi T, Berge E editor1 last Wardlaw editor1 first Joanna M title Thrombolysis for acute ischaemic stroke journal Cochrane database of systematic reviews Online volume issue 3 pages CD000213 year 2003 pmid 12917889 doi 10.1002 14651858.CD000213 ref Massive pulmonary embolism Acute limb ischae ... more details
tissue plasminogen activators r tPAs include alteplase , reteplase , and tenecteplase TNKase . ref ... it has more convenient administration and faster thrombolysis than alteplase. ref name Rivera Bou Tenecteplase ... more details
to rtPA such as reteplase and tenecteplase have been used. These newer agents boast efficacy at least ... reteplase and tenecteplase , heparin is needed to maintain coronary artery patency. Because of the anticoagulant ... more details
Encyclopedia
top
